Biopsy Devices Market Forecast to 2027 - COVID-19 impact analysis, Global Industry Size Estimation, Research Update, Future Scope, Revenue, Pricing Trends, Growth Opportunity, Regional Outlook

Global Biopsy Devices Market 2020 Research Report provides the latest information on the present and future industry trends. The Biopsy Devices Market report includes detail information about the historical as well as present growth factors of the global market. The report features major and unique factors, which are expected to significantly impact the growth of the global Biopsy Devices market during the forecast period. Biopsy Devices Market help stakeholders identify the opportunities as well as challenges.

Click Here to Get PDF Sample Copy

The biopsy devices market is anticipated to reach US$ 3,584.20 million by 2027 from US$ 2,230.86 million in 2019. The market is projected to grow at a CAGR of 6.2% from 2020 to 2027.

When cancer is suspected, a variety of biopsy techniques can be applied. An excisional biopsy is an attempt to remove an entire lesion. When the specimen is evaluated, in addition to diagnosis, the amount of uninvolved tissue around the lesion, the surgical margin of the specimen is examined to see if the disease has spread beyond the area biopsied. "Clear margins" or "negative margins" means that no disease was found at the edges of the biopsy specimen. "Positive margins" means that disease was found, and a wider excision may be needed, depending on the diagnosis.

When intact removal is not indicated for a variety of reasons, a wedge of tissue may be taken in an incisional biopsy. In some cases, a sample can be collected by devices that "bite" a sample. A variety of sizes of needle can collect tissue in the lumen (core biopsy). Smaller diameter needles collect cells and cell clusters, fine needle aspiration biopsy

Key companies Included in Biopsy Devices Market: -

BD
B. Braun Melsungen AG
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Medical LLC
Danaher
Fujifilm Corporation
Hologic, Inc.
Medtronic
Argon Medical Devices

Click here to get more information- Click here to get more information on this report

Pathologic examination of a biopsy can determine whether a lesion is benign or malignant, and can help differentiate between different types of cancer. In contrast to a biopsy that merely samples a lesion, a larger excisional specimen called a resection may come to a pathologist, typically from a surgeon attempting to eradicate a known lesion from a patient. For example, a pathologist would examine a mastectomy specimen, even if a previous nonexcisional breast biopsy had already established the diagnosis of breast cancer. Examination of the full mastectomy specimen would confirm the exact nature of the cancer (subclassification of tumor and histologic "grading") and reveal the extent of its spread (pathologic "staging").